Guenter Froeschl1,2, Michael Hoelscher1,2, Lucas Henze Maganga3, Inge Kroidl1,2, Petra Clowes1,3, Steffen Geis1, Elmar Saathoff1,2, Dieter Hoffmann2,4, Ulrike Protzer2,4, Arne Kroidl1,2. 1. Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität of Munich, Munich, Germany. 2. German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany. 3. National Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania. 4. Helmholtz Zentrum München/Technische Universität München, Institute of Virology, Munich, Germany.
Abstract
INTRODUCTION: sub-Saharan Africa bears a high prevalence for hepatitis B virus (HBV) infection. This analysis aims at elucidating the exposure to HBV across different age groups in Mbeya Region in Tanzania and determines prevalences of hepatitis C (HCV) and hepatitis delta antigen (HDV) infections. METHODS: plasma samples from children and adults with defined HIV status were analysed for HBV, HCV and HDV markers.\. RESULTS: hepatitis B (HBs)-antigen positivity was 8.3% (3/36) in the 0 to 5 years age group, 13.3% (8/60) in the 6 to 7 years, 17.2% (10/58) in the 8 to 14 years and 13.3% (8/60) in the 15 to 18 years age groups. In adults 5.0% of samples were HBs-antigen positive. Overall, 17.1% were HIV-1 positive. Adults infected with HIV-1 were significantly more often HBs-antigen positive (7.5%) than HIV-1 negative adults (4.5%; p<0.05). A serological sub-study including 174 adults showed that both total anti-HBs and total anti-HBc positivity increased with age in HBs-antigen negative participants. Across all age groups, HCV antibodies were found in 9 individuals, HDV antibodies in 3 individuals. CONCLUSION: children presented a high prevalence of HBs-antigen carriers, with lower levels in the younger children. Among adults, the overall prevalence of HBs-antigen was lower than in children, either corresponding to clearance of HBV over time or due to a die-off effect. HBs-antigen positive adults had higher frequencies of anti-HBc- and anti-HBe-antibodies, indicating better immunological control of HBV infection than children. This supports claims that HBV infections in Africa are mostly acquired in childhood and to a large extent cleared again by adulthood. One in 20 adults remains chronically infected, emphasising the importance of HBV vaccination strategies. Copyright: Guenter Froeschl et al.
INTRODUCTION: sub-Saharan Africa bears a high prevalence for hepatitis B virus (HBV) infection. This analysis aims at elucidating the exposure to HBV across different age groups in Mbeya Region in Tanzania and determines prevalences of hepatitis C (HCV) and hepatitis delta antigen (HDV) infections. METHODS: plasma samples from children and adults with defined HIV status were analysed for HBV, HCV and HDV markers.\. RESULTS: hepatitis B (HBs)-antigen positivity was 8.3% (3/36) in the 0 to 5 years age group, 13.3% (8/60) in the 6 to 7 years, 17.2% (10/58) in the 8 to 14 years and 13.3% (8/60) in the 15 to 18 years age groups. In adults 5.0% of samples were HBs-antigen positive. Overall, 17.1% were HIV-1 positive. Adults infected with HIV-1 were significantly more often HBs-antigen positive (7.5%) than HIV-1 negative adults (4.5%; p<0.05). A serological sub-study including 174 adults showed that both total anti-HBs and total anti-HBc positivity increased with age in HBs-antigen negative participants. Across all age groups, HCV antibodies were found in 9 individuals, HDV antibodies in 3 individuals. CONCLUSION: children presented a high prevalence of HBs-antigen carriers, with lower levels in the younger children. Among adults, the overall prevalence of HBs-antigen was lower than in children, either corresponding to clearance of HBV over time or due to a die-off effect. HBs-antigen positive adults had higher frequencies of anti-HBc- and anti-HBe-antibodies, indicating better immunological control of HBV infection than children. This supports claims that HBV infections in Africa are mostly acquired in childhood and to a large extent cleared again by adulthood. One in 20 adults remains chronically infected, emphasising the importance of HBV vaccination strategies. Copyright: Guenter Froeschl et al.
Authors: Steve Leumi; Jean Joel Bigna; Marie A Amougou; Anderson Ngouo; Ulrich Flore Nyaga; Jean Jacques Noubiap Journal: Clin Infect Dis Date: 2020-12-31 Impact factor: 9.079
Authors: I Merican; R Guan; D Amarapuka; M J Alexander; A Chutaputti; R N Chien; S S Hasnian; N Leung; L Lesmana; P H Phiet; H M Sjalfoellah Noer; J Sollano; H S Sun; D Z Xu Journal: J Gastroenterol Hepatol Date: 2000-12 Impact factor: 4.029
Authors: Inge Kroidl; Elmar Saathoff; Lucas Maganga; Williams H Makunde; Achim Hoerauf; Christof Geldmacher; Petra Clowes; Leonard Maboko; Michael Hoelscher Journal: Lancet Date: 2016-08-03 Impact factor: 79.321
Authors: Roland O Swai; Geofrey R Somi G; Mecky I N Matee; Japhet Killewo; Eligius F Lyamuya; Gideon Kwesigabo; Tuhuma Tulli; Titus K Kabalimu; Lucy Ng'ang'a; Raphael Isingo; Joel Ndayongeje Journal: BMC Public Health Date: 2006-04-10 Impact factor: 3.295
Authors: Jean Jacques N Noubiap; Peter V Aka; Aubin J Nanfack; Lucy A Agyingi; Johnson N Ngai; Phillipe N Nyambi Journal: PLoS One Date: 2015-09-15 Impact factor: 3.240
Authors: Steffen Andreas Schüle; Petra Clowes; Inge Kroidl; Dickens O Kowuor; Anthony Nsojo; Chacha Mangu; Helene Riess; Christof Geldmacher; Rüdiger Paul Laubender; Seif Mhina; Leonard Maboko; Thomas Löscher; Michael Hoelscher; Elmar Saathoff Journal: PLoS One Date: 2014-03-18 Impact factor: 3.240